Close Menu

NEW YORK (GenomeWeb News) – Cell Biosciences today said that it has signed a definitive agreement to acquire Alpha Innotech for $1.50 per share, or approximately $17.9 million in cash.

The acquisition will "significantly expand" Cell Biosciences' protein analysis business and provide it with a global infrastructure and broad protein analysis product portfolio, Santa Clara, Calif.-based Cell Biosciences said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal reports on the struggle to meet the demand for rapid COVID-19 testing.

The Newsroom reports New Zealand is using genomics to trace the origins of its new coronavirus outbreak.

According to Bloomberg, Moderna has a $1.5 billion vaccine deal with the US to provide 100 million doses.

In Nature this week: researchers in Canada sequence the genome of the black mustard plant Brassica nigra, and more.